Original Research Article
Year: 2022 | Month: October-December | Volume: 7 | Issue: 4 | Pages: 192-201
DOI: https://doi.org/10.52403/ijshr.20221027
Study the ENT Manifestations of Covid-19 Patients, Aden, Yemen
Saleh Mohamed Abobaker Alshaiby
Associate Professor of ENT, Department of Special Surgery, Faculty of Medicine, University of Aden, Yemen
ABSTRACT
Objective: To study and document the ENT manifestations of covid-19 infection of patients in Aden, Yemen
Materials and method: This was a retrospective descriptive study, in which we reviewed the medical records of 81 patients with Covid-19 seen at Covid-19 Treatment Center at Al-Gamhoria Teaching Hospital in Aden during the period April 2020 to March 2021.
The Fisher test was used to determine whether the difference between means and values are significant. A p-value <0.05 was considered statistically significant.
Results: Out of 81 patients, 52 patients were males (64.2%) and 29 patients (35.8%) were females and the mean age was 40.2 ±13.9 years.
The mean age of male patients was 41.8 ± 13.6 years while for females was 37.3 ± 14.5 years. The age ranged between 18 to 66 years; the association between means is statistically significant, in addition the age group < 45 years represented 59.3%.
Anosmia-dysgeusia with sore throat and pharyngeal erythema, were the most common ENT manifestations, 77.8%, and 77.8% respectively. The male patients had a higher probability of developing ENT manifestations.
The relation between anosmia-dysgeusia and sex was statistically significant (p < 0.05).
The manifestation of anosmia-dysgeusia more common among patients of the age group < 45 years with 43.2%.
Fever was found in (93.8%) patients, followed by general weakness & fatigue in (85.2%), sleep disorders in (84.0%), and muscular ache in (79.0%).
Among comorbid conditions diabetes mellitus was found as most common in (16.0%) patients.
Conclusion: The most common ENT manifestations were anosmia-dysgeusia with sore throat and pharyngeal erythema.
Keywords: ENT manifestations, general symptoms, comorbid diseases, Covid-19, Aden.